Profile
BIAFW DHR-PB TMO DHR IQV A
Company Name bioAffinity Technologies, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $26.98M $916.76B $228.67B $195.02B $41.90B $41.65B
Employees 0.01K 79.00K 122.00K 61.00K 88.00K 17.40K
CEO Ms. Maria Zannes J.D. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
BIAFW DHR-PB TMO DHR IQV A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BIAFW DHR-PB TMO DHR IQV A
Last Close $2 $1261.26 $598.61 $270.03 $229.84 $144.97
High 52 $2 $1261.26 $624.21 $280.76 $259.1 $154.64
Low 52 $0.05 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High 0 % 0 % -4.1 % -3.82 % -11.29 % -6.25 %
Price vs. 52 Week Low 3900 % 0 % 38.76 % 45.88 % 29.74 % 43.29 %
Total Return
BIAFW DHR-PB TMO DHR IQV A
1 Month Return 66.67 % 0 % -2.08 % 1.44 % -5.44 % 5.66 %
3 Month Return 446 % 0 % 10.83 % 12.87 % 10.45 % 14.72 %
6 Month Return 185.31 % 0 % 3.3 % 10.54 % -4.81 % 0.59 %
9 Month Return 1679.36 % 0 % 12.68 % 17.26 % 4.23 % 11.04 %
YTD Return 2225.58 % 0 % 12.78 % 16.72 % -0.67 % 4.27 %
1 Year Return 2464.1 % 0 % 20.07 % 24.31 % 15.71 % 31.03 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIAFW DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.49 % 0.25 % 0.49 % - 0.65 %
Dividend Paid and Capex Coverage Ration (TTM) -124.6 % 3.16 % 4.82 % 3.04 % 3.98 % 2.79 %
Dividend Per Share (TTM) - 1.32 % 1.52 % 1.32 % - 0.94 %
Payout Ratio (TTM) - 17.87 % 8.92 % 18.46 % - 19.25 %
Growth
BIAFW DHR-PB TMO DHR IQV A
Asset Growth -32.51 % 0.16 % 1.62 % 0.16 % 5.3 % 2.19 %
Gross Profit Growth 12400.53 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth 52627.44 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year - 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year - 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year - 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -98.78 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth 2.66 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share 7.91 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share -102.39 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share -102.39 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -98.78 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -48.32 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG -130.66 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG -104.49 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG -104.49 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 49.72 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 49.72 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -77.39 % 5.13 % 7.75 % 5.13 % 8.21 % 12.05 %
Share Holder 3 Year Equity Growth Per Share 127.17 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share 201.47 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share 201.47 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - -1.19 % 16.73 % -1.19 % - 7.8 %
Dividend 3 Year Growth Per Share - 28 % 59.21 % 28 % - 25.46 %
Dividend 5 Year Growth Per Share - 80.2 % 104.77 % 80.2 % - 51.49 %
Dividend 10 Year Growth Per Share - 1389.16 % 125.8 % 1389.16 % - 97.03 %
Debt Growth 527.08 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -41.25 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
BIAFW DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 29.33 % 58.45 % 41.29 % 59.41 % 29.7 % 54.86 %
Return on Assets TTM -131.24 % 5.33 % 6.32 % 5.35 % 5.39 % 12.85 %
Return on Equity TTM -170.13 % 8.42 % 13.45 % 8.04 % 22.79 % 23.4 %
Return on Capital Employed TTM -200.22 % 7.39 % 8.59 % 6.21 % 10.68 % 17.47 %
Net Income Per EBT TTM 100.16 % 83.98 % 90.7 % 99.88 % 94.99 % 91.75 %
EBT Per Ebit TTM 100.61 % 94.74 % 95.32 % 94.37 % 70.93 % 102.39 %
EBIT Per Revenue TTM -118.51 % 21.3 % 16.99 % 21.13 % 13.9 % 23.15 %
Cash Flow To Debt Ratio TTM -1389.54 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Receivables Turnover TTM 4.58 7.76 4.49 6.4 4.61 5.3
Payables Turnover TTM 6.1 6.49 9.76 5.21 3.23 5.9
Inventory Turnover TTM 173.68 4.12 4.78 3.21 - 3
Fixed Asset Turnover TTM 418.64 % 463.28 % 456.22 % 367.49 % 1979.04 % 449.31 %
Asset Turnover TTM 109.91 % 31.45 % 42.99 % 26.87 % 57.58 % 59.09 %
Operating Cash Flow Per Share TTM -0.62 9.27 24.47 8.74 13.39 6.16
Free Cash Flow Per Share TTM -0.62 7.39 20.85 6.92 10.03 4.89
Cash Per Share TTM 7.04 % 937.04 % 2312.57 % 321.85 % 920.97 % 613.45 %
Operating Cash Flow Sales Ratio TTM -96.05 % 26.52 % 22.08 % 30.55 % 16.05 % 27.49 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.8 % 79.76 % 85.18 % 79.14 % 74.88 % 79.34 %
Cash Flow Coverage Ratios TTM -1389.54 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Price To Free Cash Flows Ratio TTM -3.47 35.15 28.72 38.22 22.93 29.4
Price To Operating Cash Flows Ratio TTM -2.95 29.13 24.46 30.89 17.16 23.54
Price Cash Flow Ratio TTM -2.95 29.13 24.46 30.89 17.16 23.54
Income Statement (TTM)
BIAFW DHR-PB TMO DHR IQV A
Revenue $0B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $0B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 21.4% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.01B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.01B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -0.91 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
BIAFW DHR-PB TMO DHR IQV A
Long Term Debt $0B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $0B $31B $51.88B $31B $20.57B $4.92B
Total Equity $0B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.01B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
BIAFW DHR-PB TMO DHR IQV A
Net Income $-0.01B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $-0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-0.82B $-0.52B $-0.82B $0B $-0.27B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 144.97
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.3695
AWH Aspira Women's Health Inc. 0.822
BDSX Biodesix, Inc. 1.69
BIAF bioAffinity Technologies, Inc. 1.82
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.4596
BNR Burning Rock Biotech Limited 3.71
CDNA CareDx, Inc 30.91
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.43
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 190.74
CSTL Castle Biosciences, Inc. 29.35
DGX Quest Diagnostics Incorporated 150.79
DHR Danaher Corporation 270.03
DHR-PA Danaher Corporation 1841.01
Unlock